Retatrutide for Weight Loss: Results, Dosing, Side Effects

You already know what GLP-1s can do. You probably lost on semaglutide, stalled, switched to tirzepatide, lost more, and stalled again. Now you want the drug the community calls "Godzilla," and you want it to move the scale one more time without draining your energy or taking your muscle. The drug is the easy part. The hard part is the gray market around it: vials from strangers, forged lab reports, midnight forum math. This page gives you the real trial numbers and a safer way to get there.

One thing said plainly. Retatrutide is investigational and not FDA-approved for any use. Compounded retatrutide is not FDA-approved either, and the FDA does not review it for safety, effectiveness, or quality. Every number on this page comes from a clinical trial and names that trial. None of it promises your result. A licensed provider decides whether any treatment fits you.

What is retatrutide?

Retatrutide (development code LY3437943) is an investigational, once-weekly shot from Eli Lilly. One molecule works on three hormones at once: GLP-1, GIP, and glucagon. That is why people call it a "triple agonist," a drug that works on three hormone targets together. It reaches more of your appetite and metabolism at once than the single or dual drugs you already know (Eli Lilly; Jastreboff et al., NEJM 2023).1

GLP-1 and GIP quiet appetite and steady blood sugar. Glucagon, the third arm, is meant to raise energy use and push the body toward burning fat. The energy-use idea comes from glucagon physiology research, not the retatrutide weight-loss trial, which did not measure energy expenditure. This is not a promise of a metabolism boost.

Here is why that matters. Your weight is not a willpower score. It is biology. When you cut calories, your body fights to hold its fat the way it would in a famine. GLP-1 and GIP quiet your appetite, the same way semaglutide and tirzepatide do. Glucagon, the third hormone, is the new piece, and it is the reason the next section exists. Retatrutide is the first weight-loss drug to put it to work.

Glucagon, the third hormone, and why people hope reta won't drain them

Glucagon is reta's third hormone, and it is the part everyone talks about. The short version: when you diet, your body burns fewer calories to protect itself. Glucagon runs the other way. In human studies, switching on the glucagon receptor raised the calories people burned and pushed the body to burn fat (Muller et al., Int J Mol Sci 2019).8 Reta is the first weight-loss drug to add glucagon on top of GLP-1 and GIP.

Glucagon works against the diet slowdown and favors fat burning, and retatrutide is the first of these drugs to put it to work.

Here is how that works in plain words. When you lose weight, your body burns fewer calories than your smaller size alone would predict. Researchers call this adaptive thermogenesis, and it is well documented in humans (Rosenbaum and Leibel, Int J Obes 2010).11 It is a survival reflex, not a discipline problem. It is why diets stall. It is also why people feel flat and drained while the weight comes off. In the Biggest Loser follow-up, resting metabolism still sat hundreds of calories a day below normal six years later (Fothergill et al., Obesity 2016).10

That drained feeling is exactly what people describe on sema and tirz. The food noise (the constant pull to eat) goes quiet, but so does everything else. One user put it like this: "Tirz zapped my energy. Reta gave it back." Another: "The fog lifted. I could think clearly for the first time in over a year." Glucagon is the reason people hope for that. It works against the diet slowdown and favors fat burning. In human research, glucagon raised the calories people burned by roughly 100 to 240 a day and pushed the body to burn fat, including fat stored in the liver (Muller et al., Int J Mol Sci 2019; Whewell et al., Int J Obes 2022).9

In reta's own trials, it produced large weight loss, big drops in liver fat, and a rise in a fat-burning marker in the blood (Jastreboff et al., NEJM 2023; Sanyal et al., Nat Med 2024).7 The calorie-burning numbers above come from glucagon research, not from the reta trial itself, so we credit those studies rather than stamp the numbers on you.

Now the other side, because it is the reason supervision wins. Some people feel more tired or run cold early, especially at a dose jump. The same glucagon can nudge your resting heart rate up. None of that is a reason to panic. A clinician handles it with a slower dose ramp, shot timing, and electrolytes, which is why you want a doctor raising your dose, not a Telegram vendor. We cover heart rate next.

How much weight do people actually lose on retatrutide?

A lot, in the trials, more than any obesity drug still in testing. In the phase 2 NEJM trial, the highest-dose group lost up to 17.5% of body weight at 24 weeks and up to 24.2% at 48 weeks (Jastreboff et al., NEJM 2023; Eli Lilly).2 In December 2025, Lilly reported phase 3 topline results from TRIUMPH-4: up to 28.7% at 68 weeks, an average of more than 70 pounds. That 28.7% is a topline figure, with full peer-reviewed data still pending (HCPLive; PharmExec).5 The placebo group lost about 2.1%. That is the gap between doing this with the drug and doing it on diet and willpower alone.

Here is the detail most people skim past. In the 48-week phase 2 trial, people were still losing weight when the study ended (Eli Lilly). The loss had not leveled off. Your own result depends on your body, your dose, and your doctor's plan, which is the whole reason a plan beats a guess. For the month-by-month shape of those numbers, see what a retatrutide before and after actually looks like.

Is my vial real and correctly dosed? The prescribed path versus the gray market

This is the loudest fear in the community, and it should be. Most of the reta world online is gray-market. People buy research-only vials labeled "not for human consumption" from strangers. The lab report that comes with the vial can be forged. Reddit teardowns have found the same label claim 60% purity on one test and 95% on another. Weak doses, contamination, wrong strengths, and outright fakes are all on record. People admit they cannot tell what they injected, and they get scammed. "Please don't ask people on the internet. They will scam you," one user warned. None of them have a doctor watching their back.

The prescribed path is calmer than the forums make it sound. A doctor licensed in your state writes the script. A licensed US pharmacy fills it. You stop testing a powder from a stranger. You stop guessing whether your vial is "g2g," forum slang for good to go. You stop checking your own injection for quality. That is exactly why you want a doctor, not a stranger shipping research chemicals.

Here is the honest line, said once. Because retatrutide was never FDA-approved, it was never on an FDA drug-shortage list, which is the path that opened compounding for semaglutide and tirzepatide. The FDA's position is that there is no legal basis under federal law to compound retatrutide, and it is not on the 503A bulk drug substances list. We do not call compounded retatrutide FDA-blessed or clearly legal. We say the supervised, pharmacy-filled route, run by a provider, is the responsible way to do something this new. It removes the single scariest part of going it alone.

Will it make me tired, and what about my heart rate?

Both stories are real, and a doctor is how you land on the good one. Plenty of people feel more energized on reta than on sema or tirz, the opposite of the flat "blah" those drugs gave them. That is the hopeful read on glucagon. Others feel more tired or run cold early or at a dose jump. What separates the two is often how fast the dose climbs, and that is a doctor's call.

A slower dose ramp, shot timing, and electrolytes are the usual fixes. On your own, you guess at them. With a doctor, someone adjusts them for you.

On heart rate, the fear we hear most: in the trials, reta raised resting heart rate a little, and more at higher doses (Jastreboff et al., NEJM 2023).1 Some people on higher doses report a resting rate of 100 to 110 and think fen-phen. Here is the straight answer. That is exactly the kind of number to watch, not ignore, and watching it is what a doctor does. A doctor tracks your heart rate and blood pressure, tells you when a number matters, and adjusts your dose. Go it alone on a research chemical and nobody watches that number for you, which is the whole problem with the gray market.

The dosing math, and why you are not doing it alone

The thing that stops people at the start is not the injection. It is the math. How much water do you add to the powder? How do milligrams turn into units on a syringe? The calculators disagree and spit out "33.3 units." One person begged a forum, "the peptide calculators keep giving me different numbers, someone please help me, and be kind." Another got told, "Bruh if you can't do basic maths, you shouldn't be injecting a research chemical." Under all of it sits the fear of ruining a vial that cost real money.

With prescribed care, that whole problem disappears. A doctor sets your dose. The pharmacy mixes it and labels it. You do not mix the powder. You do not measure the dose. You do not ask "is my math mathing." You inject the dose on the label, which is why a doctor's plan beats a calculator you do not trust.

For context only, the phase 2 trial studied 1 mg, 4 mg, 8 mg, and 12 mg once weekly, each one reached by raising the dose slowly over time. Raising it slowly helps the body adjust and cuts side effects (Jastreboff et al., NEJM 2023).1 There is no FDA-approved dose, because the drug is still in trials, so your starting dose and every step is a doctor's decision, not a chart you have to crack alone at midnight. Our retatrutide dosing schedule walks through the provider-paced ramp step by step.

Can I switch from tirzepatide or semaglutide to reta?

Many people land here after a stall. The pattern is familiar: lose on semaglutide, stall, switch to tirzepatide, lose more, stall again, and now you want to know whether reta's third hormone can move the scale one more time. Some switch because their old drug zapped their energy or, in their words, "took all my muscle and left me saggy."

The honest answer first: if it ain't broke, don't fix it. If your current drug still works and you feel good, you may have no reason to change.

If you do switch, the dose does not carry over one-to-one. Guessing is how people end up feeling nothing or, as one put it, "mega sick." A doctor sets the new dose and raises it safely, which is the part you cannot get on your own. No trial has tested reta head-to-head against tirz or sema, so comparing weight-loss percentages across separate trials is a rough guide, not a verdict (NEJM 2023). For the full side-by-side, see retatrutide vs tirzepatide, semaglutide, and Ozempic.

What are the side effects of retatrutide?

The most common side effects in the phase 2 trial hit the gut: nausea, vomiting, diarrhea, and constipation. They beat placebo, ran mostly mild to moderate, tracked with the dose, and showed up mainly while the dose was climbing (Jastreboff et al., NEJM 2023). This is not a side-effect-free drug, and you deserve the straight read: 6% to 16% of people on reta quit because of harmful effects, depending on dose, compared with none on placebo (Jastreboff et al., NEJM 2023).1

Beyond the gut, people report a few other things. The higher heart rate covered above. A tingling, sunburn-like feeling on the skin. Blood sugar dips in some people without diabetes. And the usual worry about keeping muscle during fast loss. The dose climbs slowly in part to manage all of this, one more reason dosing belongs with a doctor who can adjust it, not a guess you cannot take back. Our guide to retatrutide side effects and how they are managed covers each one and the hold-dose rule.

How do you get retatrutide, and what does it cost?

Because retatrutide is still in trials, access has conditions. You cannot buy it off a shelf. Through telehealth, the path starts with a short, free health check. A licensed doctor reads your information and decides whether a weight-loss treatment is right for you. You only pay if a doctor prescribes. With Get Pep'd, every plan is built around you and your own bloodwork, every script comes from a doctor licensed in your state, and every fill comes from a licensed US pharmacy.

On cost, here is the honest version. A drug still in trials has no public price, so the monthly number depends on your dose and plan. We show the price plainly on the retatrutide cost page. We do not bury it, and we do not pretend it is the cheapest thing going. What you pay for is the right dose, a trusted pharmacy you do not have to check yourself, and a doctor watching your numbers. The gray market is cheaper right up until the vial is fake, and the longer you go it alone, the longer you gamble. If you are ready to start, here is how to get retatrutide online the prescribed way.

This content is for educational purposes and is not medical advice. Retatrutide is investigational and not FDA-approved for any use. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Trial figures cited here are average results from the named clinical trials, not a promise of individual results. A licensed provider determines whether any treatment is appropriate for you. Results vary.